Enhancing drug discovery using genetically diverse mouse models
Researchers suggest that integrating genetically diverse mouse models with cell-based assays will better replicate human diseases.
List view / Grid view
Researchers suggest that integrating genetically diverse mouse models with cell-based assays will better replicate human diseases.
The study highlights the possible therapeutic significance of targeting the pathway for treating obesity and metabolic disease.
Understanding the signalling pathway controlling neural stem cell reactivation could offer a strategy for using existing drugs to treat neurodevelopmental disorders.
Orlando Health Orlando Regional Medical Center is the first hospital in the world to use the blood test.
The discovery that eFT508 blocks eIF4E and the ketogenic pathway could provide the foundation for personalised therapies.
Five distinct CRC prognostic subtypes were identified, which could revolutionise the way CRC is diagnosed and treated.
Researchers showed that internal stress, induced by active cell behaviours, shapes the Drosophila wing disc pouch during eversion.
Genome and transcriptome sequencing revealed that subtypes such as TCF3/4::HLF were associated with an increased risk of relapse.
Increased gene activity in the SYK pathway could be the basis of a blood test to identify melanoma patients most susceptible to severe side effects.
The novel strategy demonstrates a strong immune response, both body-wide and specifically in the upper respiratory tract, in porcine models.
Scientists discovered the number of Tr1 cells increased as tumours grew larger, making mice insensitive to immunotherapy.
Researchers have developed a new form of immunotherapy that could provide a longer life expectancy to men with prostate cancer.
A biomaterial that improved hyaline cartilage repair could be used to avoid knee replacements and treat injuries and degenerative diseases.
The new technique could be adapted to produce a wide range of antibodies to combat chronic conditions like HIV.
Researchers utilised AI to identify genes that reprogramme GBM cancer cells into dendritic cells within the tumour.